Pharmaceuticals News and Research

RSS

Drug therapy can improve outcomes for acutely ill heart patients

A drug therapy used for patients with chronic heart failure also improves markers of poor prognosis in individuals who are hospitalized with acute heart failure, new Yale-led research shows.

12 Nov 2018

Fish oil and vitamin D pills no guard against cancer or serious heart trouble

A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems in healthy older people, according to research presented Saturday at the American Heart Association Scientific Sessions. Researchers defined serious heart problems as the combined rate of heart attacks, stroke and heart-related deaths.

12 Nov 2018

Cholesterol control revised in the latest AHA/ACC guidelines

The American Heart Association and the American College of Cardiology have released their latest 121 page guidelines on risk assessment and management of high cholesterol for people who are at a greater risk of heart attacks or strokes.

11 Nov 2018

Cholesterol-lowering drug reduces chance of having second heart problems or stroke

In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.

8 Nov 2018

House Dems in new seats of power will steer health policy, attack drug prices

For the first time since passing the Affordable Care Act, Democrats will soon control the House of Representatives and its powerful health committees. But Republicans' tightened grip on the Senate means those hoping for another round of dramatic, progressive reforms may be disappointed.

7 Nov 2018

California dreamin’? With Newsom’s win, single-payer unlikely to follow anytime soon

Californians on Tuesday elected a governor who campaigned for a complete overhaul of how people get their health coverage — but they shouldn't hold their breath.

7 Nov 2018

Experts identify barriers to using stroke-preventing anticoagulants in Canada

International guidelines recommend direct oral anticoagulants over warfarin to prevent stroke for most patients with atrial fibrillation.

5 Nov 2018

New heart drug spotlights troubling trends in drug marketing

At the end of September, Amarin Corp. teased some early findings for Vascepa, its preventive medicine for people at risk of heart disease.

2 Nov 2018

C-Path, CHDI and CDISC announce availability of Huntington's Disease Therapeutic Area User Guide

The Huntington's Disease Regulatory Science Consortium, launched in March 2018 by the Critical Path Institute and CHDI Foundation, today, along with the Clinical Data Interchange Standards Consortium, announce the open availability of a newly developed Huntington's Disease Therapeutic Area User Guide

2 Nov 2018

New form of therapy may stop or reverse progressive vision loss

A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness.

1 Nov 2018

NeuroPointDX launches NPDX AA test to identify metabolic subtypes associated with autism

NeuroPointDX, a division of Stemina Biomarker Discovery, today announced the commercial launch of its NPDX AA test, which identifies metabolic subtypes associated with autism spectrum disorder.

1 Nov 2018

Scientists working hard to better understand endometriosis

About 10 percent of women worldwide suffer from endometriosis, a painful and debilitating disease with inadequate treatments.

1 Nov 2018

Newly developed technology can predict large volumes of unknown biochemical reactions

Fujitsu Laboratories Ltd., the Insight Centre for Data Analytics, a data analytics research institution based in Ireland, and Fujitsu (Ireland) Limited today announced the development of a technology that makes it possible to predict large volumes of unknown chemical reactions, about twice as many as the conventional procedure.

31 Oct 2018

Scientists describe novel conjugates made from antibodies and protein inhibitor

Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects--especially when treating tumors. In the journal Angewandte Chemie, scientists have now described novel conjugates made from antibodies and a kinesin spindle protein inhibitor.

31 Oct 2018

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919).

29 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Pharmaceuticals News and Research

Drug therapy can improve outcomes for acutely ill heart patients

Fish oil and vitamin D pills no guard against cancer or serious heart trouble

Cholesterol control revised in the latest AHA/ACC guidelines

Cholesterol-lowering drug reduces chance of having second heart problems or stroke

House Dems in new seats of power will steer health policy, attack drug prices

California dreamin’? With Newsom’s win, single-payer unlikely to follow anytime soon

Experts identify barriers to using stroke-preventing anticoagulants in Canada

New heart drug spotlights troubling trends in drug marketing

C-Path, CHDI and CDISC announce availability of Huntington's Disease Therapeutic Area User Guide

New form of therapy may stop or reverse progressive vision loss

NeuroPointDX launches NPDX AA test to identify metabolic subtypes associated with autism

Scientists working hard to better understand endometriosis

Newly developed technology can predict large volumes of unknown biochemical reactions

Scientists describe novel conjugates made from antibodies and protein inhibitor

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Trump adds a global pricing plan to wide attack on drug prices, but doubts persist

New method for making mirrored forms of molecules

Global leaders in medical and surgical eye care to convene in Chicago to attend AAO 2018

Research shows link between higher generic drug use and Medicare Part D star ratings

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring